A recent study conducted by researchers at Mass General Brigham in Boston suggests that statins, widely prescribed cholesterol-lowering medications, may also help reduce the risk of frailty in older adults. The study analyzed health data from nearly one million U.S. Army veterans aged 67 and older who were initially not frail and not using statins.

Over a follow-up period extending up to 16 years, the researchers observed that individuals who began taking statins within five years were 24 percent less likely to develop frailty compared to those who did not start the medication. Frailty in this context was characterized by symptoms such as muscle loss, fatigue, slow walking speed, and low physical activity levels.

Importantly, the protective effect of statins was also evident in participants who showed early signs of frailty at the study’s outset, indicating that these drugs might offer benefits even when initiated after the initial onset of frailty. The investigators attribute these potential benefits to the anti-inflammatory properties of statins, which may help counteract biological aging processes and prevent functional decline beyond their established role in lowering cholesterol.

Frailty affects an estimated 10 percent of individuals over 65 years old, with prevalence rising to 25 to 50 percent among those aged 85 and older. Given that approximately seven million people in the United Kingdom are currently prescribed statins, the findings could have implications for strategies aimed at maintaining health and independence in the aging population.

Dr. Saadia Qazilead, one of the study’s lead authors, emphasized the significance of these results, noting that there are currently no medications specifically approved to prevent frailty. She suggested that statins may represent a valuable option to mitigate frailty risk and support healthier aging.

While the study highlights a promising association, it did not establish a definitive causal relationship, and further research is needed to confirm the potential role of statins in frailty prevention. Nevertheless, these findings contribute to a growing body of evidence exploring additional benefits of statin therapy beyond cardiovascular protection.